sRAGE alleviates SARS-CoV-2-induced pneumonia in hamster

Signal Transduct Target Ther. 2022 Feb 2;7(1):36. doi: 10.1038/s41392-022-00883-6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • COVID-19 / complications
  • COVID-19 / genetics*
  • COVID-19 / virology
  • Combined Modality Therapy
  • Cricetinae
  • Disease Models, Animal
  • Gene Expression Regulation / genetics
  • Humans
  • Lung / drug effects
  • Lung / metabolism
  • Lung / virology
  • Pneumonia / genetics*
  • Pneumonia / pathology
  • Pneumonia / therapy*
  • Pneumonia / virology
  • Receptor for Advanced Glycation End Products / genetics*
  • Receptor for Advanced Glycation End Products / therapeutic use
  • SARS-CoV-2 / pathogenicity

Substances

  • Antiviral Agents
  • Receptor for Advanced Glycation End Products
  • sRAGE protein, human